Yingbin Liu, MD, PhD, FACS
3 clinical trials · Sponsor
◉ Watch Yingbin Liu, MD, PhD, FACS
| Record | Firm | Date |
|---|---|---|
| MSCAN: ctDNA Methylation as Prognostic and Theranostic Tool for Pancreatic Cancer (NCT07045571) | Yingbin Liu, MD, PhD, FACS | 2022-10-30 |
| A Cell-free DNA Methylation Blood-Based Test for Biliary Tract Cancers Screening (NCT07176962) | Yingbin Liu, MD, PhD, FACS | 2020-01-01 |
Track Yingbin Liu, MD, PhD, FACS automatically
Every clearance here is in the API, with alerts when new ones post.